Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Parallel, Phase 3, Two-arm Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B With or Without Inhibitory Antibodies to Factors VIII or IX

NCT07285460 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07285460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Parallel, Phase 3, Two-arm Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B With or Without Inhibitory Antibodies to Factors VIII or IX
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Recruiting
Start date
December 18, 2025
Completion date
December 30, 2031
Enrollment
85 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia